期刊文献+

磁转染MUC1/Y基因入树突状细胞抗膀胱肿瘤的免疫效应研究 被引量:4

The induction of specific CTL against bladder cancer by MUC1/Y gene-modified dendritic cells which transfected with dextran coated magnetic iron oxide nanoparticles in the magnetic field
下载PDF
导出
摘要 目的:研究体外磁转染人MUC1/Y基因至人树突状细胞(DC)的可行性,以及在体外诱导特异性抗MUC1/Y膀胱癌的免疫效应。方法:以葡聚糖磁性纳米颗粒(DMN)作为载体,在多聚赖氨酸(PLL)的辅助下,通过静电作用结合MUC1/Y基因的真核表达载体pEGFP-C1-MUC1/Y,在铜-硼-锡磁块的固定磁场作用下转染至人DC中,荧光显微镜下以及流式细胞仪观察其转染效率;再将这种转基因DC与自体T细胞共培养,观察其致敏的细胞毒性T淋巴细胞(CTL)对MUC1/Y特异性抗膀胱癌(膀胱肿瘤BIU87细胞系)的杀伤活性,即分别用LDH释放法检测CTL杀伤活性和透射电镜观察CTL诱导靶细胞凋亡情况;ELISA法测定基因修饰后的DC刺激自体T细胞分泌IFN-γ的能力。结果:pEGFP-C1/-MUC1/Y转染效率为15%左右,荧光显微镜下可观察到明显绿色荧光蛋白的表达;与自体T细胞混合培养后能诱导出显著的MUC1/Y特异性的CTL,对BIU87细胞的杀伤实验表明T-DC-MUC1的杀伤活性约为52%,显著高于对照组T-DC诱导的CTL;在透射电镜下也可以清楚的观察到部分BIU87膀胱肿瘤细胞出现了细胞核核仁消失,染色质浓集于核膜周围等早期凋亡表现;基因修饰后的DC能刺激自体T细胞分泌高水平的IFN-γ,与未转染的DC相比差异有统计学意义(P<0.05)。结论:葡聚糖磁性纳米颗粒(DMN)在固定磁场的作用下成功将MUC1/Y基因转入DC,并可有效诱导出特异性的抗MUC1/Y膀胱癌的免疫效应。 Objective:To examine the ability of plasmid DNA encoding the human MUC1/Y to elicit antigenspecific CTL responses by gene transfer mediated by dextran coated magnetic iron oxide nanoparticles (DMN) as gene carrier in the magnetic field in vitro. Methods: The dextran coated magnetic iron oxide nanopartieles (DMN) modified with Poly L-Lysine (PI.L) as gene carrier transfect plasmld pEGFP-C1 MUC1/Y as the reporter gene in to human dendritic cells (HDC) in the magnetic field using Nd-Fe-B permanent magnet in vitro, and the rate of transfection of plasmid pEGFP C1-MUC1/Y into human dendritic cells are evaluated under fluorescence microscope and flow cytometer 24 hours later. After transfection . the transfected and nontransfected DC are cocultured with autogenetic T cells respectively . and seven days later with targeted bladder cancer cells (BIU87), The cytotoxic activity or apoptosis of induced CTI. to BIU87 is detected with LDH release assay or transmission electron microscope respectively. The IFN-γ secretion of the CTL are detected by EI.ISA assays. Results:DMN acts as a vector in the magnetic field to transfect reporter gene pEGFP-C1 MUC1/Y into HDC and GFP is successfully expressed, 24halter transfection . and the rate of transfectionof plasmid pEGFP-C1 MUC1/Yis 15%. The transfected DC (DC- MUC1/Y ) can successfully induced CTL with autogenetic T cells cocuhured seven days later. The cytotoxic activity of induced CTL to BIU87 by T-DC-MUC1/Y is obviously higher than that by T DC, Trans mission electron microscope map show apoptosis in the earlier period of induced CTL to BIU87, for instance, ento- blast disappearance.chromatin enriched around nuclear membrane, et al. There is significant difference in the ability of IFN-γ secretion between the transfected and nontransfected DC groups. Conclusions: Superparamagnetic dextran coated magnetic iron oxide nanoparticles (DMN) as a vector can transfect plasmid pEGFP-C1 MUC1/Y into HDC in the magnetic field successfully, and MUC1/Y protein can enhance the ability of DC to stimulate autogenetic T cells proliferation and induce most potent cytotoxicity of CTL to bladder cancer cells(BIU87).
出处 《临床泌尿外科杂志》 2007年第5期379-382,共4页 Journal of Clinical Urology
基金 国家自然科学基金资助项目(30271300)
关键词 MUC1/Y基因 膀胱癌 人树突状细胞 免疫效应 葡聚糖磁性纳米颗粒 转染 Gene pEGFP C1-MUC1/Y Bladder cancer Human dendritic cells immunological effect Dextran coated magnetic iron oxide nanoparticles Human dendritic cells Gene carrier
  • 相关文献

参考文献8

  • 1Baruch A, Hartmann M, Zrihan-Licht S, et al. Preferential expression of novel MUC1 tumor antigen isoforms in human epithelial tumors and their tumor-potentiating function[J]. Int J Cancer,1997,71(5):741-749.
  • 2冯作化,皇普系穆主编.分子生物学基本实验技术[M].出版地:出版社,2000.6.
  • 3孙璇,孙凯,曹正国,郭新,庄乾元,周四维.葡聚糖磁性纳米颗粒在基因转染人树突状细胞中的研究[J].中华实验外科杂志,2005,22(9):1113-1115. 被引量:11
  • 4Schut I C, Waterfall P M, Ross M,et al. MUC1 expression, splice variant and short form transcription (MUC1/Z, MUC1/Y) in prostate cell lines and tissue[J]. BJU Int. 2003 Feb;91(3):278-83.
  • 5Steven G S, Poulam M P, Joanne P, et al. Human dendritic cells genetically engineered to express a melanoma polypitope DNA vaccine induce multiple cytotoxic T-cell responses[J]. Clin Cancer Res, 2001,7 : 4253-4261.
  • 6Soares M M, Mehta V, Frati L, et al. Transfected human dendritic cells to induce antitumor immunity[J].Gene Ther,2000,7(17) : 1458-1466.
  • 7Pecher G, Spahn G, Schirrmann T, et al. Mucin gene (MUC1) transfer into human dendritic cells by cationic liposomes and recombinant adenovirus[J]. Anticancer Res, 2001,21(4A):2591-2596.
  • 8David W, O'Neill S A, Nina B. Manipulating dendritic cells biology for the active immunotherapy of cancer[J]. Blood,2004, 104(8): 2235-2246.

二级参考文献7

  • 1解军,徐钧,于保锋,胡晓年,程牛亮,牛勃.肝特异性非病毒基因治疗载体介导增强型绿色荧光蛋白基因在小鼠肝细胞及肝脏中的表达[J].中华实验外科杂志,2004,21(10):1163-1164. 被引量:1
  • 2冯作化 皇甫永穆.分子生物学基本实验技术(第1版)[M].武汉:同济医科大学出版社,2000.1-155.
  • 3Song SY, Kim HS. Strategies to improve dendritic cell-based immunotherapy against cancer. Yonsei Med J, 2004, 45:48-52.
  • 4Lundqvist A, Noffz G, Pavlenko M, et al. Nonviral and viral gene trans-fer into different subsets of human dendritic cells yield comparable efficiency of transfection. J Immunother, 2002, 25:445-454.
  • 5Chikh G, Sehutze-Redelmeier MP. Liposomal delivery of CTL epitopes to dendritic cells. Biosci Rep, 2002, 22 : 339-353.
  • 6Plank C, Seherer F, Sehillinger U, et al. Magnetofection: enhancing and targeting gene delivery with superparamagnetic nanoparticles and magnetic fields. J Liposome Res, 2003, 13 : 29-32.
  • 7周平红,姚礼庆,秦新裕,陆伟跃.磁性阿霉素纳米脂质体的研制及其磁靶向定位研究[J].中华实验外科杂志,2004,21(4):492-492. 被引量:18

共引文献10

同被引文献37

  • 1于津浦,任秀宝,刘虹,曹水,郝希山.pMAGE-A1/EGFP转染的人树突状细胞体外诱导特异性抗肿瘤免疫效应的研究[J].中华微生物学和免疫学杂志,2005,25(10):806-807. 被引量:1
  • 2王永权,彭毅志,王强,王逸涛,游波.脂质体介导的基因转染对人未成熟树突状细胞成熟特性的影响[J].中华烧伤杂志,2006,22(3):203-206. 被引量:4
  • 3蔡丹,王志华,胡志全,张旭,周四维,叶章群.膀胱癌患者外周血树突状细胞的体外培养扩增和鉴定[J].中华泌尿外科杂志,2006,27(7):472-474. 被引量:2
  • 4Gilboa E.DC-based cancer vaccines[J].J Clin Invest,2007;117(5):1195-1203.
  • 5van Drunen L D H S,Hannaman D.Electroporation for DNA immunization:clinical application[J].Expert Rev Vaccines,2010;9(5):503-517.
  • 6Smits E L,Anguille S,Cools N et al.Dendritic cell-based cancer gene therapy[J].Hum Gene Ther,2009;20(10):1106-1118.
  • 7Donkuru M,Badea I,Wettig S et al.Advancing nonviral gene delivery:lipid-and surfactant-based nanoparticle design strategies[J].Nanomedicine (Lond),2010;5(7):1103-1127.
  • 8Wang B,He J,Liu C et al.An effective cancer vaccine modality:lentiviral modification of dendritic cells expressing multiple cancer-specific antigens[J].Vaccine,2006;24(17):3477-3489.
  • 9Miller G,Lahrs S,Pillarisetty V G et al.Adenovirus infection enhances dendritic cell immunostimulatory properties and induces natural killer and T-cell-mediated tumor protection[J].Cancer Res,2002;62(18):5260-5266.
  • 10Melhem N M,Gleason S M,Liu X D et al.High-level antigen expression and sustained antigen presentation in dendritic cells nucleofected with wild-type viral mRNA but not DNA[J].Clin Vaccine Immunol,2008;15(9):1337-1344.

引证文献4

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部